The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Use of HER2 gene amplification to identify patients with metastatic colorectal cancer resistant to anti-EGFR monoclonal antibodies.
Cecilia Barbara
No relevant relationships to disclose
Vittoria Martin
No relevant relationships to disclose
Francesca Molinari
No relevant relationships to disclose
Lorenza Landi
No relevant relationships to disclose
Alice Riva
No relevant relationships to disclose
Piercarlo Saletti
No relevant relationships to disclose
Sara de Dosso
No relevant relationships to disclose
Ravit Geva
No relevant relationships to disclose
Sabine Tejpar
Research Funding - Merck Serono; Pfizer
George Fountzilas
No relevant relationships to disclose
Konstantine T. Kalogeras
No relevant relationships to disclose
Milo Frattini
No relevant relationships to disclose
Federico Cappuzzo
No relevant relationships to disclose